These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11193386)

  • 21. Genotoxicity risk assessment of diversely substituted quinolines using the SOS chromotest.
    Duran LT; Rincón NO; Galvis CE; Kouznetsov VV; Lorenzo JL
    Environ Toxicol; 2015 Mar; 30(3):278-92. PubMed ID: 24106140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo mutagenicity and DNA adduct levels of heterocyclic amines in Muta mice and c-myc/lacZ double transgenic mice.
    Davis CD; Dacquel EJ; Schut HA; Thorgeirsson SS; Snyderwine EG
    Mutat Res; 1996 Sep; 356(2):287-96. PubMed ID: 8841498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substituent effect of a fluorine atom on the mutagenicity of nitroquinolines.
    Saeki K; Murakami R; Kohara A; Shimizu N; Kawai H; Kawazoe Y; Hakura A
    Mutat Res; 1999 May; 441(2):205-13. PubMed ID: 10333534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo mutational analysis of liver DNA in gpt delta transgenic rats treated with the hepatocarcinogens N-nitrosopyrrolidine, 2-amino-3-methylimidazo[4,5-f]quinoline, and di(2-ethylhexyl)phthalate.
    Kanki K; Nishikawa A; Masumura K; Umemura T; Imazawa T; Kitamura Y; Nohmi T; Hirose M
    Mol Carcinog; 2005 Jan; 42(1):9-17. PubMed ID: 15486947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the metabolites of benzo[f]quinoline and benzo[h]quinoline formed by rat liver homogenate.
    LaVoie EJ; Adams EA; Hoffmann D
    Carcinogenesis; 1983 Sep; 4(9):1133-8. PubMed ID: 6883636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocarcinogen quinoline induces G:C to C:G transversions in the cII gene in the liver of lambda/lacZ transgenic mice (MutaMouse).
    Suzuki T; Wang X; Miyata Y; Saeki K; Kohara A; Kawazoe Y; Hayashi M; Sofuni T
    Mutat Res; 2000 Nov; 456(1-2):73-81. PubMed ID: 11087898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polycyclic hydrocarbons induction of diphtheria toxin-resistant mutants in human cells.
    Rocchi P; Ferreri AM; Borgia R; Prodi G
    Carcinogenesis; 1980 Sep; 1(9):765-7. PubMed ID: 11219867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of mutagenicity-deprived 3-fluoroquinoline: comparison with mutagenic quinoline.
    Saeki K; Takahashi K; Kawazoe Y
    Biol Pharm Bull; 1993 Mar; 16(3):232-4. PubMed ID: 8364465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-dependent differences in the profile of mutations induced by carcinogenic (R,S,S,R) bay- and fjord-region diol epoxides of polycyclic aromatic hydrocarbons.
    Conney AH; Chang RL; Cui XX; Schiltz M; Yagi H; Jerina DM; Wei SJ
    Adv Exp Med Biol; 2001; 500():697-707. PubMed ID: 11765016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 10-aza-substitution on benzo[a]pyrene mutagenicity in vivo and in vitro.
    Yamada K; Suzuki T; Kohara A; Hayashi M; Hakura A; Mizutani T; Saeki K
    Mutat Res; 2002 Nov; 521(1-2):187-200. PubMed ID: 12438015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutagenicity of pyridine- and quinoline-carbohydroxamic acid derivatives.
    Lipczynska-Kochany E; Iwamura H; Takahashi K; Hakura A; Kawazoe Y
    Mutat Res; 1984 Mar; 135(3):139-48. PubMed ID: 6369125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detoxification of optically active bay- and fjord-region polycyclic aromatic hydrocarbon dihydrodiol epoxides by human glutathione transferase P1-1 expressed in Chinese hamster V79 cells.
    Seidel A; Friedberg T; Löllmann B; Schwierzok A; Funk M; Frank H; Holler R; Oesch F; Glatt H
    Carcinogenesis; 1998 Nov; 19(11):1975-81. PubMed ID: 9855012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The aza-arenes as mutagens for Salmonella typhimurium.
    Seixas GM; Andon BM; Hollingshead PG; Thilly WG
    Mutat Res; 1982; 102(3):201-12. PubMed ID: 6755231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medium-term rat liver bioassay for rapid detection of carcinogens and modifiers of hepatocarcinogenesis.
    Ito N; Hasegawa R; Imaida K; Takahashi S; Shirai T
    Drug Metab Rev; 1994; 26(1-2):431-42. PubMed ID: 8082578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutagenicity of cyclopenta-fused polynuclear aromatic hydrocarbons and a non-polar fraction from a fuel combustion sample in a Salmonella forward mutation assay without exogenous metabolic activation.
    Busby WF; Smith H; Plummer EF; Lafleur AL; Mulder PP; Boere BB; Cornelisse J; Lugtenburg J
    Mutat Res; 1997 Jul; 391(3):117-25. PubMed ID: 9268036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of initiation potential of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in an in vivo carcinogen bioassay system.
    Tsuda H; Takahashi S; Yamaguchi S; Ozaki K; Ito N
    Carcinogenesis; 1990 Apr; 11(4):549-52. PubMed ID: 2322995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoprevention of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced colonic and hepatic preneoplastic lesions in the F344 rat by cruciferous vegetables administered simultaneously with the carcinogen.
    Kassie F; Uhl M; Rabot S; Grasl-Kraupp B; Verkerk R; Kundi M; Chabicovsky M; Schulte-Hermann R; Knasmüller S
    Carcinogenesis; 2003 Feb; 24(2):255-61. PubMed ID: 12584175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats--an approach for a new medium-term bioassay system.
    Ito N; Tsuda H; Tatematsu M; Inoue T; Tagawa Y; Aoki T; Uwagawa S; Kagawa M; Ogiso T; Masui T
    Carcinogenesis; 1988 Mar; 9(3):387-94. PubMed ID: 3345580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of the mutagenic effects of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) in bacteria with rat-liver 9000 x g supernatant or monolayers of rat hepatocytes as an activation system.
    Holme JA; Brunborg G; Alexander J; Trygg B; Bjørnstad C
    Mutat Res; 1988 Jan; 197(1):39-49. PubMed ID: 3275882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.